# Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B

> **NCT01943799** · PHASE2 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 178 (actual)

## Conditions studied

- Chronic HBV Infection

## Interventions

- **BIOLOGICAL:** GS-4774
- **DRUG:** OAV Regimen

## Key facts

- **NCT ID:** NCT01943799
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-13
- **Primary completion:** 2014-09-09
- **Final completion:** 2015-03-03
- **Target enrollment:** 178 (ACTUAL)
- **Last updated:** 2019-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01943799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01943799, "Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01943799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*